Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23616659 | 1.00 | GPR84 (0.47) | GPR84CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL23777965 | 0.86 | GPR84 (0.59) | GPR84NFKB1FFAR1FFAR4HAO1 | |
| SCHEMBL29539859 | 0.80 | GPR84 (0.68) | GPR84CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL54112 | 0.80 | — | — | |
| SCHEMBL20843 | 0.80 | — | — | |
| SCHEMBL2932369 | 0.80 | SLC22A6 (0.39) | GPR84SLC22A6 | |
| SCHEMBL604612 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL10664736 | 0.78 | GPR84 (0.65) | GPR84CHRM1AKR1A1CHRM3HTR2A | |
| Water SCHEMBL1672220 | 0.78 | GPR84 (0.65) | GPR84CHRM1AKR1A1CHRM3HTR2A | |
| Methane SCHEMBL28702836 | 0.78 | GPR84 (0.65) | GPR84CHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-12258610-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-11692208-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230109883-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM, INC. | 2023-04-13 | — | — | US | disclosed |
| US-20220372528-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM, INC. | 2022-11-24 | — | — | US | disclosed |
| EP-3959328-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | Zymochem, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |
| EP-3875590-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND CORYNEFORM BACTERIUM | Green Earth Institute Co., Ltd. (JP) | 2021-09-08 | — | — | EP | disclosed |
| CN-111315888-A | Method for producing organic compound and coryneform bacterium | 绿色地球研究所株式会社 | 2020-06-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | HPD, PGD, ADSL | GPR84 4363/4885CHRM1 4465/4885AKR1A1 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.